| Elise Scoggin, DO | |
|
1259 S Cedar Crest Blvd, Suite 100, Allentown, PA 18103-6372 | |
| (610) 437-4134 | |
| (610) 437-2118 |
| Full Name | Elise Scoggin |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 11 Years |
| Location | 1259 S Cedar Crest Blvd, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023420361 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | OT015672 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blessing Hospital | Quincy, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blessing Hospital | 3072422534 | 345 |
News Archive
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
A national research funding organization dedicated to improving patient-centered outcomes in the health care system has awarded $1.5 million to a team of Indiana University-Purdue University Indianapolis researchers to study how staff burnout affects the treatment and progress of mental health patients.
Providing "targeted" social support to other people in need activates regions of the brain involved in parental care- which may help researchers understand the positive health effects of social ties, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published in the Lippincott Portfolio by Wolters Kluwer.
The American College of Rheumatology today announced its 2017 health policy priorities, providing detailed policy recommendations to improve access to care and treatments for the 54 million Americans living with arthritis and other rheumatologic diseases.
Scientists at Imperial College London have identified four new proteins that act as receptors for an essential signalling molecule in bacteria such as MRSA.
› Verified 8 days ago
| Entity Name | Blessing Corporate Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851311641 PECOS PAC ID: 5991616138 Enrollment ID: O20050222000479 |
News Archive
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
A national research funding organization dedicated to improving patient-centered outcomes in the health care system has awarded $1.5 million to a team of Indiana University-Purdue University Indianapolis researchers to study how staff burnout affects the treatment and progress of mental health patients.
Providing "targeted" social support to other people in need activates regions of the brain involved in parental care- which may help researchers understand the positive health effects of social ties, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published in the Lippincott Portfolio by Wolters Kluwer.
The American College of Rheumatology today announced its 2017 health policy priorities, providing detailed policy recommendations to improve access to care and treatments for the 54 million Americans living with arthritis and other rheumatologic diseases.
Scientists at Imperial College London have identified four new proteins that act as receptors for an essential signalling molecule in bacteria such as MRSA.
› Verified 8 days ago
| Entity Name | Blessing Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1114471737 PECOS PAC ID: 3072422534 Enrollment ID: O20161005001836 |
News Archive
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
A national research funding organization dedicated to improving patient-centered outcomes in the health care system has awarded $1.5 million to a team of Indiana University-Purdue University Indianapolis researchers to study how staff burnout affects the treatment and progress of mental health patients.
Providing "targeted" social support to other people in need activates regions of the brain involved in parental care- which may help researchers understand the positive health effects of social ties, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published in the Lippincott Portfolio by Wolters Kluwer.
The American College of Rheumatology today announced its 2017 health policy priorities, providing detailed policy recommendations to improve access to care and treatments for the 54 million Americans living with arthritis and other rheumatologic diseases.
Scientists at Imperial College London have identified four new proteins that act as receptors for an essential signalling molecule in bacteria such as MRSA.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elise Scoggin, DO 1259 S Cedar Crest Blvd, Suite 100, Allentown, PA 18103-6372 Ph: (610) 437-4134 | Elise Scoggin, DO 1259 S Cedar Crest Blvd, Suite 100, Allentown, PA 18103-6372 Ph: (610) 437-4134 |
News Archive
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
A national research funding organization dedicated to improving patient-centered outcomes in the health care system has awarded $1.5 million to a team of Indiana University-Purdue University Indianapolis researchers to study how staff burnout affects the treatment and progress of mental health patients.
Providing "targeted" social support to other people in need activates regions of the brain involved in parental care- which may help researchers understand the positive health effects of social ties, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published in the Lippincott Portfolio by Wolters Kluwer.
The American College of Rheumatology today announced its 2017 health policy priorities, providing detailed policy recommendations to improve access to care and treatments for the 54 million Americans living with arthritis and other rheumatologic diseases.
Scientists at Imperial College London have identified four new proteins that act as receptors for an essential signalling molecule in bacteria such as MRSA.
› Verified 8 days ago
Dr. Arthur C Sosis, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1259 S Cedar Crest Blvd, Suite 100, Allentown, PA 18103 Phone: 610-437-4134 Fax: 610-770-0993 | |
Ronald Swinfard, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-7502 | |
Dr. Marie Susan Wagener, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 250 Cetronia Rd, Suite 301, Allentown, PA 18104 Phone: 610-437-2378 | |
Kevin Liu, DO Dermatology Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 484-862-3200 | |
Dr. Marc W Levin, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1259 S Cedar Crest Blvd, Suite 100, Allentown, PA 18103 Phone: 610-437-4134 Fax: 610-433-9690 | |
Mrs. Jane Dreas Mason, MSN, CRNP Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1259 S Cedar Crest Blvd Ste 100, Allentown, PA 18103 Phone: 610-437-4134 Fax: 610-433-9690 |